• Aucun résultat trouvé

delta biotech

N/A
N/A
Protected

Academic year: 2022

Partager "delta biotech "

Copied!
2
0
0

Texte intégral

(1)

A de Ita biotech

Agence nationale de securite du medicament et des produits de sante (ANSM) 143/147, boulevard Anatole France

93285 SAINT-DENIS CEDEX France

Buenos Aires, December 5111,2014

LETTER OF ACCESS TO OUR EUROPEAN DMF FOR TRA VOPROST (Internal DMF reference number TV/04/2014-10)

Number of Active Substance Master File: Travoprost TV /04/2014/ I 0

Manufacturing site: Delta Biotech S.A. - Annenia 3881, Carapachay, Vicente Lopez - Pcia.

Buenos Aires- Argentina

Active Substance Master File holder: Delta Biotech S.A. - Annenia 3881, Carapachay, Vicente Lopez Pcia. Buenos Aires - Argentina

The aforementioned Active Substance Master File holder hereby authorizes the ANSM, to refer to and review the above mentioned Active Substance Master File in support of the following Marketing Authorization Application submitted by Laboratoire CHAUVIN for:

Travoprost Chauvin, 40 microgrammes/ml, oogdruppels, solution eye drops

DC: DK/H/2475/001/DC MA number:-

Laboratoire CHAUVIN 416 rue Samuel Morse

cs

99535

34961 MONTPELLIER Cedex 2- Froncc

Delta Biotech S.A.

Armenia 3881 - (B1605CEI) Carapachay Pcla. de Buenos Aires - Argentina Tei./Fax: (5411) 4700-8025 (rotativas) info@deltab1otech.com.ar-www.deltabiotech.com.ar

(2)

delta biotech

It is assumed that all and any information contained in this document is to be regarded as:

I. a trade secret as it contains unpubli,shed detajls and results of private research proprietary to the DMF holder. the disclosure of which to its competitors could be disadvantageous;

and

2. commercial or financial information that is privileged or confidential in that it contains data which is used in its business and is of a type customarily used in confidence, or regarded as privileged, and has not been disclosed to any member of the public by the DMF holder.

The DMF holder certifies that all operations. procedures, materials and specifications will be in conformance with said Master File.

The aforementioned Active Substance Master File holder commits to ensure batch to batch consistency and to inform Laboratoire CHAUVIN and the ANSM, of any change in the Active Substance Master File.

For Delta Biotech S.A.

Delta Biotech S.A.

Armenia 3881 - (Bl605CEI) Carapachay

Pcla. de Buenos Aires -Argentina Tei./Fax: (5411) 4700-8025 (rotativas) info@deltablotech.com.ar- www.deltabiotech.com.ar

Références

Documents relatifs

In effect, FTP provides means for a user to have (parts of) file activity of the sort typically initiated at the command language level.. "slaved" across

The adhering human Lactobacillus acidophilus strain LA1 inhibits the cell association and cell invasion of enteropathogens in cultured human intestinal Caco-2 cells (M.. Here,

On 23 February 2018, the European Commission (EC) was informed on the cases of seven patients treated with daclizumab beta in 2016 and 2017 who have experienced after initiation

- Amoxicilline / Acide Clavulanique EG 500mg/62,5mg 16 comprimés pelliculés - Amoxicilline / Acide Clavulanique EG 500mg/62,5mg 24 comprimés pelliculés - Amoxicilline EG

The aforementioned Active Substance Master File holder hereby authorises the Agence Nationale de Securite du Medicament et des Produits de Sante to refer to and

The aforementioned Active Substance Master File holder hereby authorizes the Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS), to refer to and review the

The aforementioned Active Substance Master File holder hereby authorizes the French National Agency for Medicines and Health Products Safety/France to refer to and review

· A partir de la 12 ème semaine d’aménorrhée et jusqu’à la naissance, tous les AINS, par l’inhibition de la synthèse des prostaglandines, peuvent exposer le fœtus à